Clinical Trial Update: Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide

View source ↗

Summary

A multicenter study evaluating the response of meningioma to treatment with lutetium-177 dotatate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• LUTATHERA (Lutetium Lu-177 dotatate)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Meningioma | Status: COMPLETED